News

QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology

QDX proudly announces that the team led by its co-founder, Associate Professor Giuseppe Barca, has been honoured with the 2024 ACM Gordon Bell Prize, often referred to as the "Nobel Prize of high-performance computing."

QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs

QDX, a computational drug discovery company, today announced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology company, targeting undisclosed, previously undrugged oncology targets.

Game-changing quantum chemistry calculations push new boundaries of exascale Frontier

A breakthrough in high-performance computing (HPC) and quantum chemistry, powered by the world’s fastest supercomputer and leading technology, is set to revolutionise drug discovery and unlock new ways

Breakthrough in high-performance computing and quantum chemistry revolutionises drug discovery

A team led by University of Melbourne Associate Professor Giuseppe Barca (pictured) has achieved the first quantum simulation of biological systems at a scale necessary to accurately model drug performance.